The effect of bariatric surgery type on cardiac reverse remodelling.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
received:
25
07
2023
accepted:
16
01
2024
revised:
10
01
2024
medline:
1
2
2024
pubmed:
1
2
2024
entrez:
31
1
2024
Statut:
aheadofprint
Résumé
Bariatric surgery is effective in reversing adverse cardiac remodelling in obesity. However, it is unclear whether the three commonly performed operations; Roux-en-Y Gastric Bypass (RYGB), Laparoscopic Sleeve Gastrectomy (LSG) and Laparoscopic Adjustable Gastric Band (LAGB) are equal in their ability to reverse remodelling. Fifty-eight patients underwent CMR to assess left ventricular mass (LVM), LV mass:volume ratio (LVMVR) and LV eccentricity index (LVei) before and after bariatric surgery (26 RYGB, 22 LSG and 10 LAGB), including 46 with short-term (median 251-273 days) and 43 with longer-term (median 983-1027 days) follow-up. Abdominal visceral adipose tissue (VAT) and epicardial adipose tissue (EAT) were also assessed. All three procedures resulted in significant decreases in excess body weight (48-70%). Percentage change in VAT and EAT was significantly greater following RYGB and LSG compared to LAGB at both timepoints (VAT:RYGB -47% and -57%, LSG -47% and -54%, LAGB -31% and -25%; EAT:RYGB -13% and -14%, LSG -16% and -19%, LAGB -5% and -5%). Patients undergoing LAGB, whilst having reduced LVM (-1% and -4%), had a smaller decrease at both short (RYGB: -8%, p < 0.005; LSG: -11%, p < 0.0001) and long (RYGB: -12%, p = 0.009; LSG: -13%, p < 0.0001) term timepoints. There was a significant decrease in LVMVR at the long-term timepoint following both RYGB (-7%, p = 0.006) and LSG (-7%, p = 0.021), but not LAGB (-2%, p = 0.912). LVei appeared to decrease at the long-term timepoint in those undergoing RYGB (-3%, p = 0.063) and LSG (-4%, p = 0.015), but not in those undergoing LAGB (1%, p = 0.857). In all patients, the change in LVM correlated with change in VAT (r = 0.338, p = 0.0134), while the change in LVei correlated with change in EAT (r = 0.437, p = 0.001). RYGB and LSG appear to result in greater decreases in visceral adiposity, and greater reverse LV remodelling with larger reductions in LVM, concentric remodelling and pericardial restraint than LAGB.
Identifiants
pubmed: 38297029
doi: 10.1038/s41366-024-01474-x
pii: 10.1038/s41366-024-01474-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Lewis AJM, Abdesselam I, Rayner JJ, Byrne J, Borlaug BA, Neubauer S, et al. Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2022;23:1383–90.
pubmed: 34453521
doi: 10.1093/ehjci/jeab175
Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and cardiac remodeling in adults: mechanisms and clinical implications. Prog Cardiovasc Dis. 2018;61:114–23.
pubmed: 29990533
doi: 10.1016/j.pcad.2018.07.012
Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63:10–21.
pubmed: 31759953
doi: 10.1016/j.pcad.2019.11.009
Athithan L, Gulsin GS, McCann GP, Levelt E. Diabetic cardiomyopathy: pathophysiology, theories and evidence to date. World J Diabetes. 2019;10:490–510.
pubmed: 31641426
pmcid: 6801309
doi: 10.4239/wjd.v10.i10.490
Levelt E, Mahmod M, Piechnik SK, Ariga R, Francis JM, Rodgers CT, et al. Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes. Diabetes. 2016;65:44–52.
pubmed: 26438611
doi: 10.2337/db15-0627
Rider OJ, Petersen SE, Francis JM, Ali MK, Hudsmith LE, Robinson MR, et al. Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity. Heart. 2011;97:203–8.
pubmed: 20483890
doi: 10.1136/hrt.2009.185009
Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.
pubmed: 12151467
doi: 10.1056/NEJMoa020245
Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118:3434–50.
pubmed: 35880317
doi: 10.1093/cvr/cvac120
Carbone S, Elagizi A, Lavie CJ. Obesity and mortality risk in heart failure: when adipose tissue distribution matters. Eur J Heart Fail. 2018;20:1278–80.
pubmed: 29999227
doi: 10.1002/ejhf.1279
Henry JA, Abdesselam I, Deal O, Lewis AJ, Rayner J, Bernard M, et al. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Front Endocrinol. 2023;14:1092777.
doi: 10.3389/fendo.2023.1092777
Neeland IJ. Adipo-cardiology: the next frontier in cardiovascular disease. Prog Cardiovasc Dis. 2023;78:1.
pubmed: 37156319
doi: 10.1016/j.pcad.2023.05.001
Galanakis CG, Daskalakis M, Manios A, Xyda A, Karantanas AH, Melissas J. Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery. World J Surg. 2015;39:417–23.
pubmed: 25331726
doi: 10.1007/s00268-014-2826-2
Yu H, Di J, Bao Y, Zhang P, Zhang L, Tu Y, et al. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m
pubmed: 25547054
doi: 10.1016/j.soard.2014.06.019
Olbers T, Björkman S, Lindroos A, Maleckas A, Lönn L, Sjöström L, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006;244:715–22.
pubmed: 17060764
pmcid: 1856598
doi: 10.1097/01.sla.0000218085.25902.f8
Gaborit B, Jacquier A, Kober F, Abdesselam I, Cuisset T, Boullu-Ciocca S, et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60:1381–9.
pubmed: 22939560
doi: 10.1016/j.jacc.2012.06.016
Sorimachi H, Obokata M, Omote K, Reddy YNV, Takahashi N, Koepp KE, et al. Long-term changes in cardiac structure and function following bariatric surgery. J Am Coll Cardiol. 2022;80:1501–12.
pubmed: 36229085
pmcid: 9926898
doi: 10.1016/j.jacc.2022.08.738
O’Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25:1358–65.
pubmed: 20659224
doi: 10.1111/j.1440-1746.2010.06391.x
Beamish AJ, Olbers T, Kelly AS, Inge TH. Cardiovascular effects of bariatric surgery. Nat Rev Cardiol. 2016;13:730–43.
pubmed: 27762312
doi: 10.1038/nrcardio.2016.162
Gu L, Huang X, Li S, Mao D, Shen Z, Khadaroo PA, et al. A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. BMC Surg. 2020;20:30.
pubmed: 32050953
pmcid: 7014764
doi: 10.1186/s12893-020-00695-x
Li K, Gao F, Xue H, Jiang Q, Wang Y, Shen Q, et al. Comparative study on laparoscopic sleeve gastrectomy and laparoscopic gastric bypass for treatment of morbid obesity patients. Hepatogastroenterology. 2014;61:319–22.
pubmed: 24901132
Uhe I, Douissard J, Podetta M, Chevallay M, Toso C, Jung MK, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity. 2022;30:614–27.
pubmed: 35137548
doi: 10.1002/oby.23338
Peterli R, Borbély Y, Kern B, Gass M, Peters T, Thurnheer M, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258:690–4.
pubmed: 23989054
doi: 10.1097/SLA.0b013e3182a67426
Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319:255–65.
pubmed: 29340679
pmcid: 5833546
doi: 10.1001/jama.2017.20897
Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.
pubmed: 33567185
doi: 10.1056/NEJMoa2032183
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–16.
pubmed: 35658024
doi: 10.1056/NEJMoa2206038
Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, et al. Triple–hormone-receptor agonist retatrutide for obesity—a phase 2 trial. N Engl J Med. 2023;389:514–26.
pubmed: 37366315
doi: 10.1056/NEJMoa2301972
Favre L, Marino L, Roth A, Acierno J, Hans D, Demartines N, et al. The reduction of visceral adipose tissue after Roux-en-Y gastric bypass is more pronounced in patients with impaired glucose metabolism. Obes Surg. 2018;28:4006–13.
pubmed: 30109666
pmcid: 6223744
doi: 10.1007/s11695-018-3455-x
Toro-Ramos T, Goodpaster BH, Janumala I, Lin S, Strain GW, Thornton JC, et al. Continued loss in visceral and intermuscular adipose tissue in weight-stable women following bariatric surgery. Obesity. 2015;23:62–9.
pubmed: 25384375
doi: 10.1002/oby.20932
Johansson L, Roos M, Kullberg J, Weis J, Ahlström H, Sundbom M, et al. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg. 2008;18:1297–304.
pubmed: 18392897
doi: 10.1007/s11695-008-9484-0
Bazzocchi A, Ponti F, Cariani S, Diano D, Leuratti L, Albisinni U, et al. Visceral fat and body composition changes in a female population after RYGBP: a two-year follow-up by DXA. Obes Surg. 2015;25:443–51.
pubmed: 25218013
doi: 10.1007/s11695-014-1422-8
Heath ML, Kow L, Slavotinek JP, Valentine R, Toouli J, Thompson CH. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism. 2009;58:753–8.
pubmed: 19375765
doi: 10.1016/j.metabol.2008.05.021
Pontiroli AE, Frigè F, Paganelli M, Folli F. In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery. Obes Surg. 2009;19:745–50.
pubmed: 18629594
doi: 10.1007/s11695-008-9626-4
Lubrano C, Mariani S, Badiali M, Cuzzolaro M, Barbaro G, Migliaccio S, et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes. 2010;34:1404–14.
doi: 10.1038/ijo.2010.54
Courcoulas AP. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310:2416–25.
pubmed: 24189773
pmcid: 3955952
Kokkinos A, Alexiadou K, Liaskos C, Argyrakopoulou G, Balla I, Tentolouris N, et al. Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg. 2013;23:31–8.
pubmed: 22923313
doi: 10.1007/s11695-012-0743-8
Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev. 2015;16:406–15.
pubmed: 25753297
doi: 10.1111/obr.12270
Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715–25.
pubmed: 31301983
doi: 10.1016/S2213-8587(19)30084-1
Abbasi SA, Hundley WG, Bluemke DA, Jerosch-Herold M, Blankstein R, Petersen SE, et al. Visceral adiposity and left ventricular remodeling: the Multi-Ethnic Study of Atherosclerosis. Nutr Metab Cardiovasc Dis. 2015;25:667–76.
pubmed: 26033394
pmcid: 4468023
doi: 10.1016/j.numecd.2015.03.016
Sorimachi H, Obokata M, Takahashi N, Reddy YNV, Jain CC, Verbrugge FH, et al. Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J. 2021;42:1595–605.
pubmed: 33227126
doi: 10.1093/eurheartj/ehaa823
Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.
pubmed: 14679177
pmcid: 296998
doi: 10.1172/JCI200319451
Piché ME, Clavel MA, Auclair A, Rodríguez-Flores M, O’Connor K, Garceau P, et al. Early benefits of bariatric surgery on subclinical cardiac function: contribution of visceral fat mobilization. Metabolism. 2021;119:154773.
pubmed: 33838144
doi: 10.1016/j.metabol.2021.154773
Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136:6–19.
pubmed: 28381470
pmcid: 5501170
doi: 10.1161/CIRCULATIONAHA.116.026807
Obokata M, Reddy YNV, Melenovsky V, Sorimachi H, Jarolim P, Borlaug BA. Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity. Eur J Heart Fail. 2022;24:353–61.
pubmed: 34755429
doi: 10.1002/ejhf.2377
Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg. 2016;26:1030–40.
pubmed: 26328532
doi: 10.1007/s11695-015-1866-5
Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54:718–26.
pubmed: 19679250
doi: 10.1016/j.jacc.2009.02.086
Kaier TE, Morgan D, Grapsa J, Demir OM, Paschou SA, Sundar S, et al. Ventricular remodelling post-bariatric surgery: is the type of surgery relevant? A prospective study with 3D speckle tracking. Eur Heart J Cardiovasc Imaging. 2014;15:1256–62.
pubmed: 24966185
doi: 10.1093/ehjci/jeu116
Jhaveri RR, Pond KK, Hauser TH, Kissinger KV, Goepfert L, Schneider B, et al. Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery. Surg Obes Relat Dis. 2009;5:648–52.
pubmed: 19833561
doi: 10.1016/j.soard.2009.01.011